• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Citius Oncology, Inc. - Common Stock (NQ:CTOR)

1.080 -0.020 (-1.82%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 166,030
Open 1.130
Bid (Size) 1.070 (7,200)
Ask (Size) 1.120 (17,900)
Prev. Close 1.100
Today's Range 1.055 - 1.130
52wk Range 0.5506 - 6.190
Shares Outstanding 2,355,249
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR
December 23, 2025
CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing... 
Via MarketMinute
Topics Economy Regulatory Compliance
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
December 04, 2025
Via Investor Brand Network
Topics Government

Performance

YTD
N/A
N/A
1 Month
+0.9%
+0.9%
3 Month
-39.7%
-39.7%
6 Month
-32.5%
-32.5%
1 Year
-6.1%
-6.1%

More News

Read More
News headline image
Top stock movements in today's session. ↗
December 01, 2025
Via Chartmill
News headline image
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
December 04, 2025
From BioMedWire
Via GlobeNewswire
News headline image
Citius Oncology Launches Lymphir In US For Skin Cancer ↗
December 01, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
September 19, 2025
Via Benzinga
News headline image
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗
September 08, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 02, 2025
Via Benzinga
News headline image
Citius Oncology Beats Fiscal Q3 EPS ↗
August 12, 2025
Via The Motley Fool
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
August 06, 2025
Via Investor Brand Network
Topics Government
News headline image
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
August 06, 2025
Via FinancialNewsMedia
Topics Government
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
July 16, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 16, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
July 15, 2025
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
July 15, 2025
Via Chartmill
News headline image
These stocks are moving in today's session ↗
July 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
July 14, 2025
Via Benzinga
News headline image
Which stocks are moving on Monday? ↗
July 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
July 10, 2025
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
July 10, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 10, 2025
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Thursday? ↗
July 10, 2025
Via Chartmill
News headline image
Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday ↗
July 01, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 27, 2025
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
June 27, 2025
Via Chartmill

Frequently Asked Questions

Is Citius Oncology, Inc. - Common Stock publicly traded?
Yes, Citius Oncology, Inc. - Common Stock is publicly traded.
What exchange does Citius Oncology, Inc. - Common Stock trade on?
Citius Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Citius Oncology, Inc. - Common Stock?
The ticker symbol for Citius Oncology, Inc. - Common Stock is CTOR on the Nasdaq Stock Market
What is the current price of Citius Oncology, Inc. - Common Stock?
The current price of Citius Oncology, Inc. - Common Stock is 1.080
When was Citius Oncology, Inc. - Common Stock last traded?
The last trade of Citius Oncology, Inc. - Common Stock was at 01/15/26 04:00 PM ET
What is the market capitalization of Citius Oncology, Inc. - Common Stock?
The market capitalization of Citius Oncology, Inc. - Common Stock is 2.54M
How many shares of Citius Oncology, Inc. - Common Stock are outstanding?
Citius Oncology, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap